{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:16:22Z","timestamp":1790140582605,"version":"4.0.1"},"reference-count":76,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s495401","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T10:40:22Z","timestamp":1741862422000},"page":"171-187","source":"Crossref","is-referenced-by-count":4,"title":["Economic Burden of Intravenous Decitabine Administration in Patients Affected by Acute Myeloid Leukemia Ineligible for Induction Chemotherapy and Impact of Oral Formulation Introduction: A Micro-Costing Study in Italy"],"prefix":"10.2147","volume":"Volume 17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5528-138X","authenticated-orcid":true,"given":"Alessandra","family":"Di Costanzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0322-5798","authenticated-orcid":true,"given":"Luca","family":"Loreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5811-5992","authenticated-orcid":true,"given":"Chiara","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/jlpm.2018.09.08","volume":"4","author":"Damiani","year":"2019","journal-title":"J Lab Precis Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"key":"ref4","unstructured":"AIRTUM. I numeri del cancro in Italia, 2023. (The numbers of cancer in Italy, 2023) Available from: https:\/\/www.registri-tumori.it\/cms\/pubblicazioni\/i-numeri-del-cancro-italia-2023. Accessed May, 2024."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/03008916231153698","volume":"109","author":"Calabria","year":"2023","journal-title":"Tumori"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.tracli.2015.06.249","volume":"22","author":"Cannas","year":"2015","journal-title":"Transfus Clin Biol"},{"key":"ref7","unstructured":"Societ\u00e0 Italiana di Ematologia. Linee guida leucemia mieloide acuta non promielocitica nel paziente \u2265 60 anni, 2023. (Guidelines for non-promyelocytic acute myeloid leukemia in patient \u226560 years old). Available from: https:\/\/www.iss.it\/-\/snlg-leucemia-acuta-non-promielocitica. Accessed April, 2024."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1200\/JCO.2011.38.9429","volume":"30","author":"Kantarjian","year":"2012","journal-title":"JCO"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"8427","DOI":"10.2147\/IJN.S147659","volume":"Volume 12","author":"Briot","year":"2017","journal-title":"IJN"},{"key":"ref10","unstructured":"Ministero della Salute. Regime di rimborsabilita\u2019 e prezzo, a seguito di nuove indicazioni terapeutiche, del medicinale per uso umano \u00abDacogen\u00bb. GU Serie Generale n.199 del 28-08-2018. (Reimbursement scheme and price, as a result of new therapeutic indications, of the medicinal product for human use \u00abDacogen\u00bb. Official Journal, General Series No.199 of 28-08-2018)."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/cam4.1231","volume":"6","author":"Ali","year":"2017","journal-title":"Cancer Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1182\/blood-2023-189714","volume":"142","author":"Urlu","year":"2023","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7175\/fe.v23i1.1532","volume":"23","author":"Bellone","year":"2022","journal-title":"FE"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"21480","DOI":"10.1002\/cam4.6699","volume":"12","author":"Pradelli","year":"2023","journal-title":"Cancer Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/CEOR.S97319","author":"Ponzetti","year":"2016","journal-title":"CEOR"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1002\/cncr.21860","volume":"106","author":"Balducci","year":"2006","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/j.clml.2021.09.009","volume":"22","author":"Zeidan","year":"2022","journal-title":"Clin Lymphoma Myeloma Leukemia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"20406207241257313","DOI":"10.1177\/20406207241257313","volume":"15","author":"Zeidan","year":"2024","journal-title":"Therapeutic Adv Hematol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3324\/haematol.2022.280847","volume":"108","author":"Marchesi","year":"2022","journal-title":"haematol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1007\/s00520-022-06819-8","volume":"30","author":"Ivziku","year":"2022","journal-title":"Support Care Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s41669-022-00361-3","volume":"7","author":"McCloskey","year":"2023","journal-title":"PharmacoEconomics Open"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1016\/j.clbc.2019.01.011","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Clinical Breast Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/CAD.0000000000000648","volume":"29","author":"Franken","year":"2018","journal-title":"Anti-Cancer Drugs"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2147\/PPA.S62666","author":"Bordonaro","year":"2014","journal-title":"PPA"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.bjc.6600591","volume":"87","author":"O\u2019Neill","year":"2002","journal-title":"Br J Cancer"},{"key":"ref26","unstructured":"European Medicines Agency. List of European public assessment reports. Available from: https:\/\/www.ema.europa.eu\/en\/medicines. Accessed May, 2024."},{"key":"ref27","unstructured":"European Medicines Agency. Summary of product characteristics: decitabine\/cedazuridine. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/inaqovi. Accessed May, 2024."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1182\/blood-2023-173092","volume":"142","author":"Geissler","year":"2023","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1111\/bjh.19741","volume":"205","author":"Geissler","year":"2024","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/S2352-3026(23)00338-1","volume":"11","author":"Garcia-Manero","year":"2024","journal-title":"Lancet Haematol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"v152","DOI":"10.1093\/annonc\/mdv296","volume":"26","author":"Sousa","year":"2015","journal-title":"Ann Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.eimc.2018.07.009","volume":"37","author":"Aldea Mansilla","year":"2019","journal-title":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","volume":"77","author":"Tarricone","year":"2006","journal-title":"Health Policy"},{"key":"ref35","unstructured":"SIFO. La dispensazione del farmaco oncologico orale in farmacia ospedaliera, 2020. (Oral oncology drug dispensing in hospital pharmacy, 2020). Available from: https:\/\/www.sifoweb.it\/images\/pdf\/attivita\/attivita-scientifica\/aree_scientifiche\/area_oncologica\/volume_terapie_orali.pdf. Accessed May, 2024."},{"key":"ref36","unstructured":"Pittirutti M, Scoppettuolo G. Raccomandazioni gavecelt 2021 per la indicazione, l\u2019impianto e la gestione dei dispositivi per accesso venoso, 2021. (Recommendations gavecelt 2021 for the indication, implantation and management of venous access devices, 2021)."},{"key":"ref37","unstructured":"Azienda Ospedaliera Universitaria Sassari. Procedura per la gestione dei chemioterapici antiblastici, 2014. (Procedure for the management of antiblastic chemotherapy drugs, 2014)."},{"key":"ref38","unstructured":"Commissione regionale dispositivi medici, direzione generale cura della persona, salute e welfare, settore assistenza ospedaliera - area governo del farmaco e dispositivi medici, protocollo di gestione degli accessi vascolari \u2013 giugno 2023. (regional medical devices commission, general directorate for personal care, health and welfare, hospital care sector - drug governance and medical devices area, vascular access management protocol - June 2023)."},{"key":"ref39","unstructured":"Azienda ospedaliera \u201cSanta Maria\u201d Terni. Protocollo per l\u2019allestimento dei farmaci citotossici nella UFA, 2016. (Protocol for setting up cytotoxic drugs, 2016)."},{"key":"ref40","unstructured":"Osservatorio Nazionale sull\u2019impiego dei Medicinali. L\u2019uso degli antibiotici in Italia. Rapporto Nazionale 2021. Roma: agenzia Italiana del Farmaco, 2023. (The use of antibiotics in Italy. National Report 2021. Rome: agenzia Italiana del Farmaco, 2023)."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.4065\/81.9.1159","volume":"81","author":"Maki","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"ref42","unstructured":"European Medicines Agency. Summary of product characteristics: decitabine. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/dacogen. Accessed May, 2024."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1200\/JCO.2009.23.9178","volume":"28","author":"Cashen","year":"2010","journal-title":"JCO"},{"key":"ref44","unstructured":"IQVIA Italy medical devices hospital consumption audit, annual data MAT 09\/2023."},{"key":"ref45","unstructured":"IQVIA sales data, annual data MAT 09\/2023."},{"key":"ref46","volume":"36","author":"Mandolfo","year":"2019","journal-title":"G Ital Nefrol"},{"key":"ref47","unstructured":"Ministero della Salute. Tariffe delle prestazioni di assistenza ospedaliera per acuti, per tipo di ricovero (euro). GU Serie Generale n.23 del 28-01-2013 - Supplemento ordinario n. 8, allegato 1. (Tariffs of hospital acute care, by hospitalization type (euro). Official Journal, General Series No.23 of 28-01-2013 - Ordinary Supplement No. 8, Annex 1)."},{"key":"ref48","unstructured":"Ministero della Salute. Tariffe delle prestazioni di assistenza specialistica ambulatoriale. GU serie generale n.181 del 04-08-2023. (Tariffs for outpatient specialist care services. official journal, general series No.181 of 04-08-2023)."},{"key":"ref49","unstructured":"Ministero della Salute. Riclassificazione del medicinale per uso umano \u00abAugmentin\u00bb (amoxicillina\/acido clavulanico). GU serie generale n.136 del 14-06-2014. (Reclassification of the medicinal product for human use \u00abAugmentin\u00bb (amoxicillin\/clavulanic acid). official journal, general series no.136 of 14-06-2014)."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12916-021-02204-0","volume":"20","author":"Husereau","year":"2022","journal-title":"BMC Med"},{"key":"ref51","unstructured":"Ministero dell\u2019Economia e delle Finanze. (MEF). Retribuzioni medie pro-capite 2021. (Average wages per capita 2021). Available from: https:\/\/contoannuale.rgs.mef.gov.it\/web\/sicosito\/spese-e-retribuzioni\/retribuzione-media. Accessed January, 2024."},{"key":"ref52","unstructured":"ISTAT. Rivalutazioni e documentazione su prezzi, costi e retribuzioni contrattuali. Consultato a maggio, 2024. (ISTAT. Revaluations and documentation on prices, costs, and contractual wages. Accessed May, 2024). Available from: https:\/\/rivaluta.istat.it\/. Accessed May, 2024."},{"key":"ref53","unstructured":"ISTAT. Popolazione residente in Italia al 1 Gennaio 2019-2023. (Resident population in Italy as of January 1, 2019-2023). Available from: www.istat.it. Accessed April, 2024."},{"key":"ref54","unstructured":"IQVIA Oncoview database."},{"key":"ref55","unstructured":"Otsuka estimation. Oral decitabine penetration by year, 2024."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3109\/10428194.2014.951845","volume":"56","author":"He","year":"2015","journal-title":"Leukemia Lymphoma"},{"key":"ref57","unstructured":"Catalano L, Piccinini V, Pati I, et al. Italian Blood System 2020: activity data, haemovigilance and epidemiological surveillance, 2021, iii, 103 p. Rapporti ISTISAN 21\/14."},{"key":"ref58","unstructured":"Ministero della Salute. Disposizioni relative ai requisiti di qualit\u00e0 e sicurezza del sangue e degli emocomponenti. GU Serie Generale n.300 del 28-12-2015. (Provisions on quality and safety requirements for blood and blood components. Official Journal, General Series No.300 of 28-12-2015)."},{"key":"ref59","unstructured":"Accordo Stato Regioni del 7 giugno 2023 (rep. Atti n\u00b0134\/CSR) \u201cAccordo interregionale per la compensazione della mobilit\u00e0 sanitaria aggiornato all\u2019anno 2022 - Regole tecniche\u201d. (Agreement State-Regions of 7 June 2023 - rep. Acts no. 134\/CSR - \u201cInterregional agreement for health mobility compensation updated to the year 2022\u201d)."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/CEOR.S354470","volume":"Volume 14","author":"Mastrorilli","year":"2022","journal-title":"CEOR"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1007\/s00520-022-07126-y","volume":"30","author":"Zhu","year":"2022","journal-title":"Support Care Cancer"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/hon.2663","volume":"37","author":"Bocchia","year":"2019","journal-title":"Hematol Oncol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.19.2100610","volume":"27","author":"Badia-Cebada","year":"2022","journal-title":"Eurosurveillance"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/IDR.S177247","volume":"Volume 11","author":"Haque","year":"2018","journal-title":"IDR"},{"key":"ref65","unstructured":"Eisai Inc. Trial of decitabine in patients with acute myeloid leukemia (DACO-016). Available from: https:\/\/clinicaltrials.gov\/study\/NCT00260832. Accessed April, 2024. NLM identifier: NCT00260832."},{"key":"ref66","unstructured":"Il Sole 24 ore. Cittadinanzattiva: la carenza di personale attraversa tutta l\u2019Italia, si rischia il deserto sanitario (Active Citizenship: staffing shortages run across Italy, health care desert at risk, 2023). Sanit\u00e024. 2023. Available from: http:\/\/s24ore.it\/loD3SU. Accessed April, 2024."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/annonc\/mdj023","volume":"17","author":"Twelves","year":"2006","journal-title":"Ann Oncol"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1200\/JCO.1997.15.1.110","volume":"15","author":"Liu","year":"1997","journal-title":"JCO"},{"key":"ref69","unstructured":"Eurostat. Purchasing power parities (PPP). Available from: https:\/\/ec.europa.eu\/eurostat\/en\/. Accessed April, 2023."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.clinthera.2020.03.012","volume":"42","author":"Armeni","year":"2020","journal-title":"Clin Ther"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s12020-016-0980-z","volume":"55","author":"Filetti","year":"2017","journal-title":"Endocrine"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1007\/s00464-011-2053-y","volume":"26","author":"Berto","year":"2012","journal-title":"Surg Endosc"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3111\/13696998.2014.980502","volume":"18","author":"Palmieri","year":"2015","journal-title":"J Med Economics"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/CEOR.S446560","volume":"Volume 16","author":"Gogas Yavuz","year":"2024","journal-title":"CEOR"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2147\/CEOR.S472192","volume":"Volume 16","author":"Rojas-Suarez","year":"2024","journal-title":"CEOR"},{"key":"ref76","unstructured":"Preliminary Otsuka data on file. Data on blood transfusion requirements, 2024."}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/101111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/101111","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T10:40:40Z","timestamp":1741862440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/economic-burden-of-intravenous-decitabine-administration-in-patients-a-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":76,"URL":"https:\/\/doi.org\/10.2147\/ceor.s495401","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}